ConCallIQ
Go Pro
FORTIS Diversified 15 May 2024

Fortis Healthcare Limited — Q4 FY24

Fortis Healthcare reported a strong Q4 FY24 with consolidated revenue of ₹1,786 crore (+8.7% YoY) and EBITDA margin of 21.3% (+480bps YoY), driven by hospital business margin ex...

bullish high
Compare with...
Revenue ₹1,786 Cr +8.7%
EBITDA ₹380 Cr
PAT ₹203 Cr +46.9%
EBITDA Margin 21.3% +480bps
Duration
Read Time 1 min read

✓ Verified against BSE filing

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Agilus put option liability could strain balance sheet

If PE investor exercises put option, Fortis may need to raise ~₹1,200-1,300 crore, potentially via debt or equity, impacting leverage or dilution.

high · analyst_question
R

Ongoing legal cases and brand litigation costs

Annual legal costs of ₹30-50 crore related to legacy issues (brand, forensic audit) may persist until resolution; Supreme Court stay on promoter shareholding dismissed.

medium · management_commentary
R

Diagnostics business recovery slower than expected

Agilus volumes grew only 0.6% in Q4 despite rebranding; competitive pressures and government business provisions may delay margin recovery.

medium · data_observation
R

CGHS rate revision uncertainty

Government revenue (20% of hospital) may benefit from CGHS rate revision, but timing and quantum are uncertain; not factored into guidance.

low · management_commentary